Subscribe To
TLPPF / Telix to Present at Jefferies London Healthcare Conference 2022
MELBOURNE, Australia, Nov. 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a commercial-stage biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals, advises that Dr Christian Behrenbruch, Group CEO and Managing Director, will be presenting at the Jefferies London Healthcare Conference 2022. The presentation will take place on Thursday 17 November from 3:15 – 3:45pm GMT (10:15 – 10:45am EST / 2:15 – 2:45am AEDT, 18 Nov).
Read More
Posted: Nov 11 2022, 07:00
Author Name: PRNewsWire
Views: 102188
TLPPF News
By PRNewsWire
November 11, 2022
Telix to Present at Jefferies London Healthcare Conference 2022
MELBOURNE, Australia, Nov. 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a commercial-stage biopharmaceutic more_horizontal